Tomomi Morimura

Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats

Ryuichi Kikkawa, Ikuo Hatanaka, H. Yasuda et al. · Diabetologia · 1983 · 112 citations · Full text

Medicine, Neuroscience, Pharmacology +10

Effects of a fructose-rich diet and the aldose reductase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats

Norio Hotta, Hironobu Kakuta, Hideo Fukasawa et al. · Diabetologia · 1985 · 68 citations · Full text

Medicine, Biochemistry, Pharmacology +12

A 90-day ad libitum administration toxicity study of oligoglucosamine in F344 rats

Yukiko Naito, Kazumi Tago, Tomoko Nagata et al. · Food and Chemical Toxicology · 2007 · 16 citations

Medicine, Pharmacology, Toxicology +3

A ninety-day feeding, subchronic toxicity study of oligo-N-acetylglucosamine in Fischer 344 rats

Kazumi Tago, Yukiko Naito, Tomoko Nagata et al. · Food and Chemical Toxicology · 2007 · 12 citations

Pharmacy, Biochemistry, Toxicology +3